AKT1 and cancer: STRN3 also increases the expression of PARK7 by inhibiting the proteasome-mediated degradation of PARK7 and subsequently activates AKT by enhancing the stability of PARK7 and increasing the formation of protein-protein complexes for protecting cancer cells from oxidative stress [117].